Mitiglinide
ADVERTISEMENT
- Molecular formula
- C16H19N3O2
- CAS Number
- 145375-44-4
- IUPAC Name
- 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine
- Molecular Weight
- 267.32g/mol
- Melting Point
- (Celsius)
- Boiling Point
- (Celsius)
- Density
- 1.2560g/cm3
- Synonyms
- Guanoxan
Identification
Interesting facts
Interesting Facts about 2-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)guanidine
2-(2,3-Dihydro-1,4-benzodioxin-3-ylmethyl)guanidine is a unique compound that has garnered attention in the field of medicinal chemistry and organic synthesis. Here are some intriguing aspects of this compound:
- Structure and Functionality: This compound features a benzodioxin moiety, a fused bicyclic structure that contributes to its potential biological activity. The presence of the guanidine group may enhance its reactivity and interaction with biological targets.
- Biological Activity: Research suggests that compounds like 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine may have applications in drug development due to their potential antitumor and antimicrobial properties. The investigation into these activities continues to unfold.
- Intriguing Applications: This compound could serve as an important scaffold for synthesizing new pharmaceuticals. Its versatility allows for the incorporation of various functional groups, potentially leading to novel therapeutic agents.
- Chemical Reactions: The guanidine moiety is known for its basicity, making compounds like this one interesting for studying acid-base chemistry and catalytic processes. It may also be involved in nucleophilic reactions.
- Future Research Directions: Ongoing studies aim to elucidate the mechanism of action and broaden the understanding of how the structural features of this compound contribute to its biological effects.
In conclusion, 2-(2,3-dihydro-1,4-benzodioxin-3-ylmethyl)guanidine exemplifies the fascinating intersection of organic chemistry and pharmacology. Its unique structure and potential applications make it a subject of active research and consideration in the development of new therapeutic strategies.